Botox Safety Emphasized By FDA As Botulinum Toxins Get New Generic Names

Safety efforts designed to discourage interchanging products will benefit the market leader.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet